ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $744,392 | +129.8% | 471,134 | +214.1% | 0.10% | +118.8% |
| Q2 2023 | $324,000 | +25.0% | 150,000 | +21.5% | 0.05% | +23.1% |
| Q1 2023 | $259,203 | -4.1% | 123,430 | 0.0% | 0.04% | 0.0% |
| Q4 2022 | $270,312 | -91.9% | 123,430 | -88.9% | 0.04% | -90.5% |
| Q3 2022 | $3,340,000 | +6.0% | 1,113,453 | 0.0% | 0.41% | -14.2% |
| Q2 2022 | $3,151,000 | -47.1% | 1,113,453 | 0.0% | 0.48% | -59.9% |
| Q1 2022 | $5,957,000 | -28.4% | 1,113,453 | 0.0% | 1.19% | -28.8% |
| Q4 2021 | $8,317,000 | -17.7% | 1,113,453 | 0.0% | 1.67% | -20.3% |
| Q3 2021 | $10,110,000 | – | 1,113,453 | – | 2.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 725,984 | $3,223,000 | 0.05% |
| Marquette Asset Management, LLC | 18,848 | $84,000 | 0.03% |
| FEDERATED HERMES, INC. | 1,615,000 | $7,171,000 | 0.02% |
| VIKING GLOBAL INVESTORS LP | 587,444 | $2,608,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 132,123 | $587,000 | 0.00% |
| OPPENHEIMER & CO INC | 18,343 | $81,000 | 0.00% |
| Renaissance Technologies | 365,830 | $1,624,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 80,950 | $359,000 | 0.00% |
| FMR LLC | 1,402,874 | $6,229,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 67,964 | $302,000 | 0.00% |